期刊文献+

卵巢抵抗综合征分级及病因研究 被引量:6

Grading and etiology of ovarian resistant syndrome
原文传递
导出
摘要 目的探讨卵巢抵抗综合征(ROS)的分级以及病因。方法收集2015年9月至2016年12月广州医科大学附属第三医院收治的ROS患者共6例,按基础FSH水平将ROS划分为3个等级:10 U/L<FSH<25 U/L为ROS一级,25 U/L≤FSH<40 U/L为ROS二级,FSH≥40 U/L为ROS三级,获取患者临床资料及血液标本,进行FSHR及LHCGR基因组测序。结果 6例患者均出现LHCGR(rs2293275,c.935A>G,p.Asn680Ser)突变以及部分患者出现FSHR(rs6165,c.919A>G,p.Thr307Ala)、(rs6166,c.2039A>G,p.Asn680Ser)突变。在大剂量外源性促性腺激素用药的情况下,ROS一级患者能获取少量卵子,ROS三级患者均获卵失败。结论 rs2293275突变可能与ROS发生有关,ROS等级越高,卵泡对促排卵药物反应性越差。 Objective To investigate the grading and etiology of ROS. Methods Totally 6 cases of ROS were collected at the Third Affiliated Hospital of Guangzhou Medical University from September 2015 to December 2016. According to the basic FSH level,the ROS was divided into 3 grades. The first-grade ROS range was 10 U/L≤FSH〈25 U/L,the second-grade ROS range was 25 U/L≤FSH〈40 U/L,and the third-grade ROS range was FSH≥40 U/L. Clinical data and blood samples were obtained and genomic sequencing of FSHR and LHCGR was carried out.Results LHCGR mutation(rs2293275,c.935A〉G,p.Asn680Ser)]occurred in all patients and FSHR mutation[(rs6165,c.919A〉G,p.Thr307Ala)and(rs6166,c.2039A〉G,p.Asn680Ser)occurred in some patients. The first-degree ROS patients were able to acquire small amounts of oocytes,while the third-degree ROS patients failed,in the case of large dose of exogenous gonadotropin therapy.Conclusion The rs2293275 mutation may be associated with ROS development and the higher the ROS degree,the lower the response of the follicle to ovulation induction drugs.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2017年第9期963-966,共4页 Chinese Journal of Practical Gynecology and Obstetrics
基金 广东省省级科技计划项目(2016A020218012) 广州市科技计划项目(201604020075)
关键词 卵巢抵抗综合征 分级 病因 ovarian resistant syndrome grading etiology
  • 相关文献

参考文献2

二级参考文献71

  • 1庄广伦,李洁,周灿权,张曦伟.供卵治疗卵巢早衰妊娠成功(附1例报告)[J].中山医科大学学报,1995,16(1):66-70. 被引量:17
  • 2Falck B.Site of production of oestrogen in the ovary of the rat[J].Nature,1959,184(Suppl 14):1082. 被引量:1
  • 3Eppig JJ,Hosoe M,O'brien MJ,et al.Conditions that affect acquisition of developmental competence by mouse oocytes in vitro:FSH,insulin,glucose and ascorbic acid[J].Mol Cell Endocrinol,2000,163(1-2):109-16. 被引量:1
  • 4Balasch J,Creus M,Fabregues F,et al.The effect of exogenous luteinizing hormone(LH) on oocyte viability:evidence from a comparative study using recombinant human follicle-stimulating hormone(FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction[J].J Assist Reprod Genet,2001,18(5):250-256. 被引量:1
  • 5Franco JG,Baruffi RL,Oliveira JB,et al.Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol:a matched case-control study[J].Reprod Biol Endocrinol,2009,7:58. 被引量:1
  • 6Lisi F,Rinaldi L,Fishel S,et al.Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization[J].Fertil Steril,2005,83(2):309-315. 被引量:1
  • 7Venetis CA,Kolibianakis EM,Tarlatzi TB,et al.Benefits of luteinizing hormone activity in ovarian stimulation for IVF[J].Reprod Biomed Online,2009,18 Suppl 2:31-36. 被引量:1
  • 8Kovacs P,Kovats T,Kaali SG.Results with early follicular phase recombinant luteinizing hormone supplementation during stimulation for in vitro fertilization[J].Fertil Steril,2010,93(2):475-479. 被引量:1
  • 9Kolibianakis EM,Kalogeropoulou L,Griesinger G,et al.Among patients treated with FSH and GnRH analogues for in vitro fertilization,is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis[J].Hum Reprod Update,2007,13(5):445-452. 被引量:1
  • 10Mochtar MH,Van Der V,Ziech M,et al.Recombinant luteinizing hormone(rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles[J].Cochrane Database Syst Rev,2007,(2):CD005070. 被引量:1

共引文献14

同被引文献28

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部